ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $453,846 | -9.6% | 67,941 | +13.6% | 0.00% | 0.0% |
| Q2 2023 | $501,881 | +135911.1% | 59,819 | +112766.0% | 0.00% | – |
| Q4 2022 | $369 | -100.0% | 53 | -91.8% | 0.00% | – |
| Q3 2022 | $3,450,000 | -60.7% | 646 | -70.6% | 0.00% | – |
| Q2 2022 | $8,778,000 | -73.6% | 2,200 | -70.5% | 0.00% | – |
| Q1 2022 | $33,195,000 | -16.5% | 7,468 | -24.8% | 0.00% | – |
| Q4 2021 | $39,744,000 | -47.8% | 9,936 | +14.7% | 0.00% | – |
| Q3 2021 | $76,070,000 | +264.3% | 8,664 | +370.1% | 0.00% | – |
| Q2 2021 | $20,881,000 | -94.5% | 1,843 | -94.2% | 0.00% | -100.0% |
| Q1 2021 | $378,877,000 | +3967.8% | 31,892 | +2437.2% | 0.00% | – |
| Q3 2020 | $9,314,000 | -94.1% | 1,257 | -96.7% | 0.00% | – |
| Q2 2020 | $156,721,000 | +793.8% | 37,583 | +429.4% | 0.00% | – |
| Q1 2020 | $17,535,000 | -20.8% | 7,099 | +86.2% | 0.00% | – |
| Q4 2019 | $22,148,000 | +22.4% | 3,812 | +11.0% | 0.00% | – |
| Q3 2019 | $18,097,000 | +17.0% | 3,434 | +33.2% | 0.00% | – |
| Q2 2019 | $15,468,000 | -61.0% | 2,578 | -41.3% | 0.00% | – |
| Q1 2019 | $39,642,000 | +451.3% | 4,390 | +742.6% | 0.00% | – |
| Q3 2018 | $7,190,000 | +73.6% | 521 | 0.0% | 0.00% | – |
| Q2 2018 | $4,142,000 | – | 521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,400,239 | $6,224,000 | 4.02% |
| Tri Locum Partners LP | 1,447,445 | $6,434,000 | 2.51% |
| Knoll Capital Management, LLC | 759,405 | $3,376,000 | 2.12% |
| Perceptive Advisors | 9,903,879 | $44,023,000 | 0.88% |
| JOHNSON & JOHNSON | 394,834 | $1,755,000 | 0.33% |
| APOGEM CAPITAL LLC | 104,042 | $462,000 | 0.32% |
| Ikarian Capital, LLC | 375,000 | $1,667,000 | 0.22% |
| 683 Capital Management, LLC | 500,000 | $2,223,000 | 0.12% |
| Verition Fund Management LLC | 2,105,907 | $9,361,000 | 0.11% |
| Palo Alto Investors LP | 160,800 | $715,000 | 0.06% |